The lawsuit accuses the formula maker of deceptively marketing the milks to make them seem like the next recommended step for toddlers.

A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...

Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...

Mutations in a gene called OTP cause obesity by controlling the output of another gene already targeted by an anti-obesity drug, a study led by UT Southwestern Medical Center researchers shows. The ...

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

Investors scored big wins last year as the S&P 500, the Nasdaq, and the Dow Jones Industrial Average all climbed by double ...

Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss according to a University of Illinois professor ...

LONDON: Doctors worldwide should diagnose obesity differently, relying on broader criteria and taking into account when the condition causes ill-health, according to a new framework drawn up by ...

An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA ...

Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.